Board of Directors

Fate’s Board of Directors has founded and led the evolution of several of the most successful companies in the biotechnology space. The group has deep expertise in science, technology, drug development, finance, and strategy – all the tools necessary to help Fate emerge as an industry leader in the development and commercialization of programmed cellular immunotherapies.

William Rastetter, Ph.D.
John Mendlein, Ph.D.
Vice Chairman
Dr. Shefali Agarwal
Board Member
Timothy P. Coughlin
Board Member
4bio goes here
Robert S. Epstein, M.D.
Board Member
Robert Hershberg, M.D., Ph.D.
Board Member
Karin Jooss, Ph.D.
Board Member
Michael Lee
Board Member
8bio goes here
Yuan Xu, Ph.D.
Board Member
Scott Wolchko
President & CEO
11bio goes here